Clinical trial enrollment is vital for advancing renal cell carcinoma treatment, providing access to innovative therapies and potentially better care. The STELLAR-002 study evaluated zanzalintinib ...
As medicine advances toward more individualized care, clinical diagnostics are playing an increasingly vital role. Traditionally, diagnostic tests have been used to identify and classify diseases.